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There is general agreement that the mature cells of the blood of mammals 
arise from a  pluripotent hemopoietic stem  cell  (1-4). This cell is defined by 
ability  to  form  spleen  colonies  after  injection  into  lethally  irradiated  mice 
(5)  and  is  thus  called  a  spleen  colony-forming unit  or  CFU-s.  Colonies  of 
myeloid cells can be formed in vitro  (6,  3)  and  the  cells which  give rise  to 
these colonies (CFU-c) differ in many properties from the CFU-s. The CFU-c 
appear to be slightly denser (8, 9), have a higher sedimentation rate, (8) and 
have a larger proportion of cells in S phase of the cell cycle than CFU-s  (10, 
11). It seems reasonable to consider the CFU-c as a different, more differentiated 
cell than the CFU-s which may be considered the earliest known hemopoietic 
cell.  The cell responsive to the inductive factors which either cause or allow 
expression along a  given differentiative pathway is called the progenitor cell. 
It is not clear how far removed from the stem cell the progenitor cell is in dif- 
ferentiative steps or at what stage the progenitor becomes a  determined cell. 
Once  the  progenitor  cell  has  begun  to  differentiate along  a  given pathway 
toward  an  end cell the  intermediate cell  types may be considered precursor 
cells of that end cell. 
An antigen shared with CFU-s was found in mouse brain making it possible 
to  produce  an  anti-CFU-s  (or  an  antistem  cell)  antibody  (12).  This  brain- 
associated stem cell specificity was shown to be different from brain-associated 
0  (13)  and  brain-associated  erythroid specificities (14).  Using  rabbit  or goat 
antibrain antisera it has been possible to eliminate CFU-s from bone marrow 
or spleen.  In  this paper, we have used antistem cell antiserum to show that 
the progenitor cell which is responsible for in vitro myeloid colonies does not 
share the brain-associated stem cell antigen with the pluripotent cell responsible 
for spleen colonies. Thus, a clear antigenic difference can be demonstrated to 
have occurred in early hemopoietic differentiation. 
* Supported by U.S. Public Health Service Grant AI 08800 and a grant from the Leukemia 
Research Foundation. 
Recipient of a  U.S. Public Health Service Research Career Development Award. 
THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  •  VOLUME 139, 1974  1621 1622  VAN  DEN  ENGH  AND  GOLUB  BRIEF DEFINITIVE REPORT 
Materials and Methods 
Animals.--BDF1  (C57BL/6 X  DBA/2) mice were used for all but one of the experiments. 
These  mice  were  bred  at  Purdue  using stocks  obtained  from  Jackson  Laboratories,  Bar 
Harbor,  Maine. Animals were maintained five to a  cage with driking water containing 11 
ppm chlorine at pH 2.8 (15). CBA mice were used in the double cell transfer experiment which 
was carried  out at Rijswijk.  These animals are  also maintained on low pH,  high chlorine 
water. 
X  Irradiation.--The  conditions for X  irradiation at  Purdue  were  as  described  in  (12) 
and for Rijswijk as in (16). 
Colony-Forming Unit Assays.-- 
CFU-s:  The spleen assay of Till and  McCulloch was used  (5).  Briefly, 5  X  104 bone 
marrow cells were injected i.v. into lethally irradiated  mice.  10 days later the number  of 
spleen colonies were counted. 
CFU-c:  Myeloid  precursor  cells were  assayed  essentially by  the  method  described  by 
Metcalf and Moore (17).  1 X  105 bone marrow cells were suspended in Dulbecco's medium 
with 0.3% agar.  10% colony-stimulating factor (CSF) extracted from mouse uteri according 
to the method of Bradley (18) was added and 1 ml aliquots were distributed in 35 mm Falcon 
dishes and incubated at 37C with 10% CO2 in  100% humidity.  Colonies were counted at 
day 7. The CSF levels used were those which allowed maximal expression of CFU-c. 1 
Antisera:  Antistem cell antiserum was produced  as  described previously  (12,  13).  The 
batch used in the experiments reported here was from a  goat which had received two injec- 
tions of CBA brain emulsified in complete Freund's adjuvant (13).  The standard antiserum 
was absorbed with mouse erythrocyte and liver (19). In most experiments the serum was also 
absorbed with thymus cells.  The rabbit antigoat gamma globulin was  kindly provided  by 
Dr. R. M. E. Parkhouse, Medical Research Council Laboratory, Mill Hill, London. 
RESULTS 
Effect of Antimouse Brain Antiserum on In Vivo and In Vitro Colony Forma- 
tion.--To  determine  the  effects  of  the  antistem  cell  antiserum  on  in  vitro 
colony formation (CFU-c) and in vivo colony formation (CFU-s), bone marrow 
cells  from  BDF1  mice  were  treated  with  dilutions  of  goat  antimouse  brain 
antiserum absorbed with red cells, liver, and thymus as described in Materials 
and  Methods.  After  this  treatment,  varying concentrations  of  cells were  in- 
jected  into  lethally  irradiated  BDF1  recipients  to  determine  the  numbers  of 
surviving  CFU-s or cultured  in vitro with  CSF  to  determine  the number of 
surviving CFU-c. In vitro colonies were counted at day 7 and in vivo colonies 
at day 10. The results of three such experiments are presented in Table I. 
It can be seen that  there  was  a  75-85 %  reduction  of  CFU-s but  that  the 
number of CFU-c was not significantly reduced. This result was also obtained 
with  three  separate  batches  of rabbit  anti-CBA brain  and  another  batch  of 
goat anti-CBA serum. 
Evidence that the Lack oJ Reduction of CFU-c is not due to Inefficient In Vitro 
Cytotoxicity of CFU-c.--The results in the previous section can be interpreted 
as showing that  the CFU-c does not share an antigen with CFU-s. However, 
it is necessary to show that the difference is not due to the fact that there is 
1 van den Engh, G. J. Quantitative in vitro studies on stimulation of murine haeraopoietic 
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TABLE I 
Recovery of CFU-c and CFU-s from Bone Marrow Cells Treated with Antibrain  Antiserum* 
Exp. no.  Bone marrow cells  In vitro colonies  counted (av)  In vivo colonies  counted (av) 
treated with: 
1~:  NGS  ~  30, 36, 31, 39 (34) 
Antibrain  a  ~  55, 41, 48, 49 (48) 
Antibrain  b  1/~  44, 55, 64, 63 (52) 
2§  NGS 
Anfibrain 
3][  NGS 
Anfibrain 
Not done 
60, 47, 56 (55)  25, 28, 31, 24, 26 (27) 
42, 48, 46 (45)  5, l, 3, 6, 4 (3.8) 
49, 55, 52 (52)  7, 6, 15, 8, 7 (8.6) 
~6  42, 41, 44 (42)  7, 14, 9, 7, 9 (9.2) 
~/~2  37, 38, 49 (41)  9, 19, 19, 15, 13 (15) 
1/~4  40, 55, 51  (49)  27, 14, 30, 26, 18 (23) 
~/~  78, 100 (89)  22, 14, 26, 17 (22) 
92, 78 (85)  4, 4, 4, 3, 12  (5.4) 
~/~  84, 70 (77)  12, 18, 8, 16 (11) 
~6  82, 79 (80)  2, 7, 8, 6 (5.8) 
~/~2  104, 72 (88)  10, 10, 16, 4 (10) 
~/~4  85, I10 (97)  9, 17, 19, 12  (14.2) 
* 2 X  106 BDF1 bone marrow cells in 0.2 ml were treated with an equal volume of goat 
anti-CBA brain antiserum absorbed as indicated and diluted in BSS. After 30 min at OC, 5 
ml guinea pig complement diluted ~  in BSS was added and the cells incubated for 1 h at 
37C. The indicated number of cells were  then injected into lethally irradiated BDF1 mice 
for  CFU-s assay or plated for CFU-c assay. CFU-s were  assayed on day 10  and  CFU-c 
on day 5. 
:~ 1 X  105 cells plated. Antiserum was absorbed with a) mouse RBC and b) mouse RBC 
and thymus. 
§ 1 X  l0  s cells plated and 2 X  105 cells injected for CFU-s. Antiserum was absorbed with 
RBC, thymus, and liver. 
II 2 X  105 cells plated for CFU-c assay and 8 N  104 cells injected for CFU-s assay. Anti- 
serum absorbed with RBC. 
a differential ability of cells to be lysed in vivo and in vitro. For example, both 
CFU-c  and  CFU-s  could  share  the  stem  cell  antigen  and  both  could  react 
with the antistem cell antibody but treatment with complement in vitro may 
not cause the cells to lyse. When the cells with their reacted antibody are in- 
jected into the mouse, conditions in vivo could allow lysis. The cell being tested 
for in  vitro  colony formation  would  not  be  subjected  to  this  in  vivo  action 
and would thus express itself as a  colony-forming unit even through it shared 
the antigen.  Indeed, CFU-s which have been reacted with antistem cell anti- 
body in vitro in  the absence of complement are inhibited from forming colo- 
nies in vivo. Presumably, this is due to some action of the recipient on the cell- 
antibody  complex  in  vivo.  Several  experiments  were  carried  out  to  decide 
between these alternatives. 
Effect of Antiglobulin  Treatment.--Bone  marrow  cells were treated with the 
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with  a  1/10  dilution  of  rabbit  antigoat  gamma  globulin.  After a  further  30 
min in the cold the cells were washed and treated with guinea pig complement 
for 1 h  at 37°C and then tested for ability to form in vitro colonies. Treatment 
with  the  antiglobulin antiserum  did  not  cause  any  reduction  in  CFU-c  ex- 
pression. 
The Eject of In  Vivo Passage of In  Vitro-Treated CelIs.--Bone marrow cells 
were  treated with complement alone  (Group A)  or with  antibrain plus  com- 
plement (Group B). l0  G  of these cells were then injected into lethally irradiated 
mice. One group of irradiated mice received no bone marrow cells (Group C). 
24  h  later,  the  spleens  of  these  irradiated  mice  were  harvested,  cultured  in 
vitro to determine the number of CFU-c or injected into another set of irradi- 
ated  mice  to  determine  the  number  of  surviving  CFU-s.  Thus,  if  the  host 
mouse  were  contributing  to  the  lysis  of  the  antistem  cell  antibody-treated 
cells,  there  should  be  a  reduction  in  the  number  o[  colony-forming units  in 
the spleens of these adoptive hosts when  assayed for CFU-c. If colonies were 
obtained from these irradiated hosts, i.e., if there were no reduction by passage 
through  the  animal,  this  would  argue  against  inefficient lysis in  vitro  being 
responsible for lack of reduction of CFU-c seen after in vitro treatment. 
The results of this last experiment are presented in Table II. It can be seen 
that  there  was  no  reduction  in  the number  of in  vitro  colonies formed  after 
passage of the cells through the irradiated host. 
DISCUSSION 
The  experiments  in  this  paper  were  designed  to  answer  the  question  of 
whether the progenitor cell which is responsible for in vitro colonies shares the 
TABLE II 
CFU Content of Spleens of Irradiated Hosts after Injection of Anti-CBA  Brain-Treated 
Bone Marrow* 
Treatment of bone marrow cells before passage through primary hosts-- 
CFU recovered from primary hosts 
CFU-c/spleen  CFU-s/spleen 
A.  Complement:~  65  9¶ 
B.  Goat anti-CBA brain§ -]- complement  120  2 
C.  No cells[[  5  0 
* Bone marrow  cells were treated as in Table I. 
:~ Responses  obtained  from  spleens  of  irradiated primary hosts  repopulated  with  106 
bone  marrow  cells treated with normal serum  and complement. 
§ Response obtained from spleens of irradiated primary hosts repopulated with 106 bone 
marrow cells treated with anti-CBA brain plus complement. 
][ Response  obtained from  the spleens of irradiated mice with no repopulafion of bone 
marrow. 
¶ The  original marrow  suspension  contained approximately 130  CFU-s/10  s cells.  The 
seeding efficiency for these cells after 24 h is approximately 10%. Thus the theoretical num- 
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brain-associated stem cell antigen with the cell responsible for spleen colonies. 
This was accomplished by determining if in vitro colonies were prevented from 
being  formed  after reaction of bone  marrow  cells with  antibrain  antiserum 
and complement. Antibrain sera contain antibodies which prevent the forma- 
tion of in  vivo colonies  (12),  i.e.,  antistem  cell antibodies.  The experiments 
reported here show  that  treatment of bone marrow cells with  such  an  anti- 
serum  and  complement does not prevent in  vitro colonies from forming.  It 
can be seen in Table I  that while spleen colony formation is essentially abol- 
ished,  in  vitro  colony formation is  essentially  unaffected.  Furthermore,  the 
same result was obtained with antisera absorbed with thymus and thus devoid 
of the brain-associated 0 specificity (13). 
The failure to impair expression of in vitro colonies after anti-brain antiserum 
treatment was shown not to be due to inefficient in vitro cytotoxicity. Since 
bone marrow cells which were reacted with antibody in vitro, passaged through 
an  irradiated animal  and  recovered still  were able  to form in  vitro colonies 
(Table II). 
There are a number of physical and physiological differences between CFU-c 
and CFU-s (8-11), the most striking being that the CFU-s is pluripotent but 
the CFU-c is a determined cell. The CFU-c is responsive to inductive influences 
and  microenvironments which  the  stem  cell  is  not.  The data  in  this  paper 
show  that  along with  these functional changes,  there is  an  antigenic change 
which  has  also  occurred in  the differentiation from stem  cell  to  progenitor 
cell. 
We have, as of yet, no marker antigen for the progenitor cell as we do for 
the stem cell (12), and for several later stages of differentiation of the progenitor 
cell. The cells which are derived from the lymphoid progenitor and which are 
determined to become T lymphocytes (20) under thymic influence will express a 
variety of antigens at different stages of differentiation. An example of these 
differentiation antigens (21)  on the lymphocyte in the thymus (To cell) is the 
expression of TL and 0.  After further differentiation and  the  export to  the 
peripheral lymphoid tissue, these cells become T1 and T2 (22)  thymic-derived 
lymphocytes and no longer express TL while still expressing 0.  Similarly, we 
have  demonstrated  that  B-lymphocyte precursor  cells  in  the  bone  marrow 
and  B  cells  in  the peripheral lymphoid compartments  which  are  responsive 
to the same antigen in thymic-dependent or in thymic-independent forms have 
characteristic surface antigens associated with their stage of development3 
It  is  probable  that  antigenic  differences are  associated  with  all  or  most 
stages  in  hemopoietic differentiation. If  this  is  the  case,  as  we  identify the 
antigens we will have powerful tools for the study of hemopoiesis, both normal 
and leukemic,  since we  will  be able  to identify or eliminate  cells at  specific 
stages  of differentiation. We are  currently determining if the  erythroid and 
2 Golub, E.  S.,  M. Bradshaw, I.  F.  C  McKenzie, and D.  Sachs.  Manuscript in  prepa- 
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lymphoid progenitor cells also lack the stem cell antigen  and are attempting 
to identify early lymphoid precursor cells by unique surface antigens. 
SUMMARY 
Bone  marrow  contains  pluripotent  stem  cells  which  give  rise  to  colonies 
when  injected  into  irradiated  syngenic  hosts  as  well  as  more  differentiated 
progenitor cells of the myeloid cell which  are able  to form colonies in vitro. 
Antisera against brain is known to contain antistem cell antibody. The present 
experiments  were  designed  to  determine  if  the  myeloid  progenitor  cell  still 
expresses the stem cell antigen. 
Bone marrow cells were treated with antibrain antiserum plus complement 
and  then  survival of stem cells was determined  by injection  into  irradiated 
hosts.  Survival  of myeloid progenitor cells was determined  by culturing  the 
cells in vitro.  It was found that stem cells were eliminated by the antiserum 
but that myeloid progenitors were not.  Inefficient in vitro lysis was ruled out 
as the reason for this difference since in vitro colonies were not reduced  when 
the  cells were treated with  anti-immunoglobulin or after passage  through  an 
irradiated  host.  In  the  differentiation  from stem  cell  to  myeloid  progenitor 
there is an associated surface antigen change. 
We thank Ms. Sue Radka and Ms. Laure Paul for their competent and enthusiastic technical 
help and Dr. Neil Williams for his very helpful comments during the preparation of the man- 
uscript. 
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